Results 11 to 20 of about 1,598,143 (384)

Proteases [PDF]

open access: yesCurrent Protocols in Protein Science, 2000
AbstractThe processes of growth and remodeling of cells and tissues in multicellular organisms require the breakdown of old protein molecules, in concert with the synthesis of new ones. For example, many newly‐synthesized molecules require proteolytic processing to convert them to biologically active forms.
Jennifer L. Harris, Charles S. Craik
openaire   +5 more sources

Gastric Proteases and Protease Inhibitors

open access: bronzeGastroenterology, 1967
Michael D. Turner   +2 more
openalex   +3 more sources

Protease inhibitors targeting the main protease and papain-like protease of coronaviruses [PDF]

open access: yesExpert Opinion on Therapeutic Patents, 2020
The two cysteine proteases from the coronaviruses, which produced deadly outbreaks in the last two decades, SARS CoV-1/2, and MERS, the main protease (Mpro) and the papain-like protease (PLP) are conserved among the three pathogens and started to be considered as exciting drug targets for developing antivirals.We review the drug design landscape in the
Capasso, Clemente   +2 more
openaire   +4 more sources

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

open access: yesNature, 2020
The papain-like protease PLpro is an essential coronavirus enzyme that is required for processing viral polyproteins to generate a functional replicase complex and enable viral spread 1 , 2 .
Donghyuk Shin   +21 more
semanticscholar   +1 more source

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors

open access: yesNature Communications, 2020
The pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to expand. Papain-like protease (PLpro) is one of two SARS-CoV-2 proteases potentially targetable with antivirals.
J. Osipiuk   +20 more
semanticscholar   +1 more source

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

open access: yesNature Communications, 2020
The main protease, Mpro (or 3CLpro) in SARS-CoV-2 is a viable drug target because of its essential role in the cleavage of the virus polypeptide. Feline infectious peritonitis, a fatal coronavirus infection in cats, was successfully treated previously ...
Wayne Vuong   +13 more
semanticscholar   +1 more source

In silico prediction of mutant HIV-1 proteases cleaving a target sequence [PDF]

open access: yes, 2014
HIV-1 protease represents an appealing system for directed enzyme re-design, since it has various different endogenous targets, a relatively simple structure and it is well studied.
De Vico, Luca   +3 more
core   +6 more sources

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

open access: yesNature Communications, 2020
COVID-19 was declared a pandemic on March 11 by WHO, due to its great threat to global public health. The coronavirus main protease (Mpro, also called 3CLpro) is essential for processing and maturation of the viral polyprotein, therefore recognized as an
L. Fu   +15 more
semanticscholar   +1 more source

Docking study on anti-HIV-1 activity of secondary metabolites from Zingiberaceae plants

open access: yesJournal of Pharmacy and Bioallied Sciences, 2020
Introduction: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However,
Muhammad Sulaiman Zubair   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy